Internal Medicine Journal

Cover image for Vol. 45 Issue 11

Edited By: Jeff Szer

Impact Factor: 1.644

ISI Journal Citation Reports © Ranking: 2014: 62/154 (Medicine General & Internal)

Online ISSN: 1445-5994

Recently Published Issues

See all

Top 5 Cited Papers - 2013 Impact Factor Period

Variability in vitamin D assays impairs clinical assessment of vitamin D status
J. K. C. Lai, R. M. Lucas, E. Banks, A.-L. Ponsonby and the Ausimmune Investigator Group

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
G. Cheng, C. Huang, H. Deng and H. Wang

Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies
M. Dugar, S. Cox, V. Limaye, P. Blumbergs and P. J. Roberts-Thomson

Use of empiric antimicrobial therapy in neutropenic fever
C. S. Tam, M. O'Reilly, D. Andresen, S. Lingaratnam, A. Kelly, K. Burbury, J. Turnidge, M. A. Slavin, L. J. Worth, L. Dawson and K. A. Thursky

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication
D. Tong, N. Manolios, G. Howe and D. Spencer

Editor's Choice

Antibiotic resistance: are we all doomed?

P. Collignon

Antibiotic resistance is a growing and worrying problem associated with increased deaths and suffering for people. Overall, there are only two factors that drive antimicrobial resistance, and both can be controlled. These factors are the volumes of antimicrobials used and the spread of resistant micro-organisms and/or the genes encoding for resistance. We need to look at all sectors and control not only antibiotic use but also the spread and development of antibiotic resistant bacteria – both locally and internationally.